Core sedating antihistamine product information
Safety and efficacy of loratadine (Sch- 29851): a new non-sedating antihistamine in seasonal allergic rhinitis.
Pharmacokinetic-pharmacodynamic relationships of H- antihistamines.
American Society of Health-System Pharmacists, Inc., 4500 East-West Highway, Suite 900, Bethesda, Maryland 20814. Claritin tablets, syrup and rapidly disintegrating tablets prescribing information.
† Use is not currently included in the labeling approved by the US Food and Drug Administration.
Focus on loratadine: a new second-generation nonsedating H1-receptor antagonist.
Efficacy and safety of loratadine (10 mg once daily), terfenadine (60 mg twice daily), and placebo in the treatment of seasonal allergic rhinitis.
Evaluation of the CNS properties of SCH 29851, a potential non-sedating antihistamine. Claritin-D 24 Hour (loratadine and pseudoephedrine sulfate) extended-release tablets prescribing information. Schering Corp, Kenilworth, NJ: Personal communication. Loratadine: a preliminary review of its pharmacodynamic properties and therapeutic efficacy. Over-the-counter drugs: establishment of a monograph for OTC cold, cough, allergy, bronchodilator and antiasthmatic products.